IL152590A0 - Treatment of congestive heart failure - Google Patents
Treatment of congestive heart failureInfo
- Publication number
- IL152590A0 IL152590A0 IL15259001A IL15259001A IL152590A0 IL 152590 A0 IL152590 A0 IL 152590A0 IL 15259001 A IL15259001 A IL 15259001A IL 15259001 A IL15259001 A IL 15259001A IL 152590 A0 IL152590 A0 IL 152590A0
- Authority
- IL
- Israel
- Prior art keywords
- heart failure
- congestive heart
- hydrogen
- treatment
- excretion
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Furan Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20143100P | 2000-05-03 | 2000-05-03 | |
| PCT/US2001/009265 WO2001082920A2 (en) | 2000-05-03 | 2001-03-22 | Treatment of congestive heart failure with a composition comprising a diuretic agent and a vasopressin antagonist |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL152590A0 true IL152590A0 (en) | 2003-05-29 |
Family
ID=22745788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15259001A IL152590A0 (en) | 2000-05-03 | 2001-03-22 | Treatment of congestive heart failure |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1280555B8 (xx) |
| JP (1) | JP2003535823A (xx) |
| KR (1) | KR20020093971A (xx) |
| CN (1) | CN1431915A (xx) |
| AT (1) | ATE326241T1 (xx) |
| AU (1) | AU2001249364A1 (xx) |
| BR (1) | BR0110566A (xx) |
| CA (1) | CA2407929C (xx) |
| CZ (1) | CZ20023587A3 (xx) |
| DE (1) | DE60119723T2 (xx) |
| ES (1) | ES2264444T3 (xx) |
| HU (1) | HUP0300632A3 (xx) |
| IL (1) | IL152590A0 (xx) |
| MX (1) | MXPA02010865A (xx) |
| NZ (1) | NZ522641A (xx) |
| PL (1) | PL358544A1 (xx) |
| SK (1) | SK15532002A3 (xx) |
| WO (1) | WO2001082920A2 (xx) |
| ZA (1) | ZA200209367B (xx) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040229781A1 (en) * | 2000-05-10 | 2004-11-18 | Marks Andrew Robert | Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias |
| US20200337590A1 (en) * | 2018-01-16 | 2020-10-29 | Bayer Aktiengesellschaft | Assistance in the treatment of cardiac insufficiency |
| KR20220052561A (ko) | 2020-10-21 | 2022-04-28 | 장영진 | 어류 가공물 및/또는 콩 가공물을 유효성분으로 포함하는 심부전의 예방 또는 치료용 약학 조성물 |
-
2001
- 2001-03-22 DE DE60119723T patent/DE60119723T2/de not_active Expired - Lifetime
- 2001-03-22 AT AT01922578T patent/ATE326241T1/de not_active IP Right Cessation
- 2001-03-22 IL IL15259001A patent/IL152590A0/xx unknown
- 2001-03-22 NZ NZ522641A patent/NZ522641A/en unknown
- 2001-03-22 ES ES01922578T patent/ES2264444T3/es not_active Expired - Lifetime
- 2001-03-22 JP JP2001579795A patent/JP2003535823A/ja not_active Abandoned
- 2001-03-22 WO PCT/US2001/009265 patent/WO2001082920A2/en active IP Right Grant
- 2001-03-22 HU HU0300632A patent/HUP0300632A3/hu unknown
- 2001-03-22 CA CA002407929A patent/CA2407929C/en not_active Expired - Fee Related
- 2001-03-22 BR BR0110566-3A patent/BR0110566A/pt not_active IP Right Cessation
- 2001-03-22 AU AU2001249364A patent/AU2001249364A1/en not_active Abandoned
- 2001-03-22 CZ CZ20023587A patent/CZ20023587A3/cs unknown
- 2001-03-22 SK SK1553-2002A patent/SK15532002A3/sk not_active Application Discontinuation
- 2001-03-22 KR KR1020027014636A patent/KR20020093971A/ko not_active Application Discontinuation
- 2001-03-22 CN CN01810483A patent/CN1431915A/zh active Pending
- 2001-03-22 EP EP01922578A patent/EP1280555B8/en not_active Expired - Lifetime
- 2001-03-22 MX MXPA02010865A patent/MXPA02010865A/es active IP Right Grant
- 2001-03-22 PL PL01358544A patent/PL358544A1/xx not_active Application Discontinuation
-
2002
- 2002-11-18 ZA ZA200209367A patent/ZA200209367B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2407929A1 (en) | 2001-11-08 |
| HUP0300632A2 (hu) | 2003-08-28 |
| CZ20023587A3 (cs) | 2003-06-18 |
| JP2003535823A (ja) | 2003-12-02 |
| WO2001082920A3 (en) | 2002-07-18 |
| ZA200209367B (en) | 2004-02-18 |
| EP1280555B1 (en) | 2006-05-17 |
| CN1431915A (zh) | 2003-07-23 |
| EP1280555B8 (en) | 2006-06-28 |
| ES2264444T3 (es) | 2007-01-01 |
| HUP0300632A3 (en) | 2006-02-28 |
| CA2407929C (en) | 2009-05-19 |
| SK15532002A3 (sk) | 2003-08-05 |
| BR0110566A (pt) | 2003-04-01 |
| AU2001249364A1 (en) | 2001-11-12 |
| EP1280555A2 (en) | 2003-02-05 |
| ATE326241T1 (de) | 2006-06-15 |
| KR20020093971A (ko) | 2002-12-16 |
| NZ522641A (en) | 2003-10-31 |
| DE60119723D1 (de) | 2006-06-22 |
| DE60119723T2 (de) | 2007-04-26 |
| WO2001082920A2 (en) | 2001-11-08 |
| PL358544A1 (en) | 2004-08-09 |
| MXPA02010865A (es) | 2003-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN00606A (xx) | ||
| DE60336850D1 (en) | Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren | |
| EP1177168A4 (en) | CASPASE INHIBITORS AND THEIR USE | |
| FI964815A (fi) | Piperatsiinijohdoksia 5-HT1A antagonisteina | |
| BR0014651A (pt) | Inibidores de adesão de célula mediada por "alfa" l beta2 | |
| NO20020938D0 (no) | Substituerte alfa-hydroksysyre-caspaseinhibitorer og deres anvendelse | |
| GB9919673D0 (en) | 2-Arlybenzazole compounds | |
| EA200100184A1 (ru) | Новые гидратные формы алендроната натрия, способы их получения и фармацевтические композиции | |
| FR2777424B1 (fr) | Levain panaire longue conservation pret a l'emploi | |
| TR200000786T2 (tr) | Vitronektin reseptör antagonisti | |
| GB0017988D0 (en) | Novel process | |
| UA83012C2 (ru) | Кристаллическая форма натриевой соли 3-пиридил-1-гидроксиэтилиден-1,1-бисфосфоновой кислоты | |
| YU48103A (sh) | Litijumovi kompleksi n-(1-hidroksimetil-2,3-dihidroksipropil) 1,4,7-triskarboksimetil 1,4,7,10-tetraazaciklododekana, njihovo dobijanje i primena | |
| IL152590A0 (en) | Treatment of congestive heart failure | |
| ES8607218A1 (es) | Un procedimiento para preparar compuestos de amidina | |
| PL370267A1 (en) | Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase | |
| DE60216948D1 (en) | 4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren | |
| HU0203193D0 (xx) | ||
| TWI255813B (en) | Compounds for use as alphavbeta3 receptor antagonists | |
| ZA951963B (en) | N-benzoylmethyl-piperidines | |
| TR200300551T2 (tr) | Agrokimyasal kompozisyon | |
| ATE294790T1 (de) | Chlormethylierung von thiophene | |
| YU43499A (sh) | Kristalna hidratovana natrijumova so (e)-4,6-dihloro-3- (2-okso-1-fenilpirolidin-3-iliden metil)-1h-indol-2- karboksilne kiseline | |
| DE60227113D1 (de) | Kondensierte camptothecine als antitumormittel | |
| SE0101323D0 (sv) | New process |